OpenField
Home/Researchers/Prof. Peter Flatt
United Kingdom · Diabetes therapeutics · Reviewed 2026-10-15

Prof. Peter Flatt

Prof. Peter Flatt is a world-renowned diabetes researcher who has developed multiple patent-protected GLP-1 and GIP incretin-based peptide therapeutics for metabolic disease.

Official faculty profile ↗Research checked, not sponsored

Documented research interests and leadership

Research areas
Diabetes therapeutics, Incretin hormones, Islet cell biology, Peptide chemistry
Academic position
Professor of Biomedical Sciences & Head of Diabetes Research Group
Primary university source
Official directory entry ↗
Recruitment status
Not verified. Leadership profile does not imply active vacancies or assistantship availability.

Supervision and contact

Students interested in graduate or doctoral research supervision in Diabetes therapeutics, Incretin hormones, Islet cell biology are advised to consult formal department application channels.

Important verification note

Facts reflect official university directory records reviewed 2026-10-15. Faculty recruitment and admissions require formal application.

Reviewed 2026-10-15 · Editorial standards · Report an issue